Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-24T13:54:29.994Z Has data issue: false hasContentIssue false
  • English
  • Français

Cardiac failure in an elderly population

Published online by Cambridge University Press:  17 November 2008

SJ Smith  and
Michael Lye
SJ Smith*
Affiliation:
Department of Geriatric Medicine, University of Liverpool, UK
Michael Lye
Affiliation:
Department of Geriatric Medicine, University of Liverpool, UK
*
SJ Smith, Senior Lecturer in Rehabilitation, Clatterbridge Hospital, Bebington, Wirral, Merseyside L63 4JY, UK.
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical geriatrics
Information
Reviews in Clinical Gerontology , Volume 4 , Issue 3 , August 1994 , pp. 199 - 211
Copyright
Copyright © Cambridge University Press 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Gibson, TC, White, KL, Klainer, LM.The prevalence of congestive heart failure in two rural communities. J Chron Dis 1966; 19: 141–52.CrossRefGoogle ScholarPubMed
2Parameshwar, J, Poole-Wilson, PA, Sutton, GC.Heart failure in a district general hospital. J R Coll Physicians Lond 1992; 26: 139–42.Google Scholar
3Kannel, WB, Savage, D, Castelli, WP. Cardiac failure in the Framington Study: twenty year follow up. In: Braunwald, E ed. Congestive heart failure: current research and clinical applications. New York: Grune and Stratton, 1982;: 15–30.Google Scholar
4Haavisto, M, Geiger, U, Mattila, K, Rajala, S.A health survey of the very aged in Tampere, Finland. Age Ageing 1984; 13: 266–72.CrossRefGoogle ScholarPubMed
5The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure; results of the Co-operative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429–35.CrossRefGoogle Scholar
6Kostis, JB, Moregra, AE, Amendo, MT, Pietro, JD, Cogrove, N, Kuo, PT.The effect of age on heart rate in subjects free of heart disease. Circulation 1982; 65: 141–45.CrossRefGoogle ScholarPubMed
7Darr, KC, Bassett, DR, Morgan, BJ, Thomas, DP.Effects of age and training status on heart rate recovery after peak exercise. Am J Physiol 1988; 254: H340–43.Google ScholarPubMed
8Rodeheffer, RJ, Gerstenblith, G, Becker, LC.Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation 1984; 69: 203–13.CrossRefGoogle ScholarPubMed
9Unverferth, DV, Fetter, JK, Unverferth, BJ et al. Human myocardial histologic characteristics in congestive heart failure. Circulation 1983; 68: 1194–200.CrossRefGoogle ScholarPubMed
10Weisfeldt, ML.Echocardiographic assessment of a normal adult ageing population. Circulation 1977; 56: 273–78.Google Scholar
11Cuocolo, A, Sax, FL, Brush, JE, Maron, BJ, Bacharach, SL, Bonow, RO.Left ventricular hypertrophy and impaired diastolic filling in essential hypertension, diastolic mechanisms for systolic dysfunction during exercise. Circulation 1990; 81: 978–86.CrossRefGoogle ScholarPubMed
12Sullivan, MJ, Higginbotham, MB, Cobb, FR.Exercise training in patients with severe left ventricular dysfunction. Haemodynamic and metabolic effects. Circulation 1988; 78: 506–15.CrossRefGoogle ScholarPubMed
13Massie, BM, Conway, MB, Rajagopalan, B et al. Skeletal muscle metabolism during exercise under ischaemic conditions in congestive heart failure. Circulation 1988; 78: 321–26.CrossRefGoogle ScholarPubMed
14Sullivan, MJ, Green, HJ, Cobb, FR.Skeletal muscle biochemistry and histology in ambulatory patients with long term heart failure. Circulation 1990; 81: 518–27.CrossRefGoogle ScholarPubMed
15Cohn, JN, Levine, TB, Olivari, MT et al. Plasma norepirephine as a guide to prognosis in patients with congestive cardiac failure. N Engl J Med 1984; 311: 819–23.CrossRefGoogle Scholar
16Bristow, MR, Hershberger, RE, Port, JD et al. α-adrenergic pathways in non-failing and failing human ventricular myocardium. Circulation 1990; 82 (suppl 1): 12–25.Google Scholar
17Lakatta, EG, Yin, FC.Myocardial ageing: Function alterations and related cellular mechanisms. Am J Physical 1982; 242: H927–41.Google ScholarPubMed
18Lye, M, Vargas, E, Faragher, EB, Davies, I, Goddard, C.Haemodynamic and neurohumoral responses in elderly patients with postural hypotension. Eur J Clin Invest 1990; 20: 90–96.CrossRefGoogle ScholarPubMed
19Vargas, E, Lye, M, Faragher, EB, Goddard, C, Moser, W, Davies, I.Cardiovascular haemodynamics and the response of vasopressin, aldosterone, plasma renin activity and plasma catecholamines to head-up tilt in young and old healthy subjects. Age Ageing 1986; 1: 17–28.CrossRefGoogle Scholar
20Hollenberg, NK, Adams, DF, Solomon, HS.Senescence and the renal vasculature in normal man. Circ Res 1974; 34: 309–16.CrossRefGoogle ScholarPubMed
21Lerman, A, Gibbons, RJ, Rodeheffer, RJ et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left ventricular dysfunction. Lancet 1993; 341: 1105–109.CrossRefGoogle ScholarPubMed
22Franciosa, JA, Park, M, Levine, B.Lack of correlation between exercise capacity and indices on left ventricular performance. Am J Cardiol 1981; 47: 33–39.CrossRefGoogle Scholar
23Davies, SW, Fussell, AL, Jordan, SL et al. Abnormal diastolic filling patterns in chronic heart failure, relationship to exercise capacity. Eur Heart J 1992; 13: 749–57.CrossRefGoogle ScholarPubMed
24Parameshwar, J, Dambrink, JHE, Sparrow, J et al. A new exercise test for the assessment of heart failure: use of a self powered treadmill. Br Heart J 1989; 61: 421–25.CrossRefGoogle ScholarPubMed
25Pfeffer, MA, Braunwald, E, Moye, LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327: 669–77.CrossRefGoogle ScholarPubMed
26Soufer, R, Wohlgelertner, D, Vita, NA et al. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985; 55: 1032–36.CrossRefGoogle ScholarPubMed
27Topol, EJ, Traill, TA, Fortuin, NJ.Hypertensive hypertrophic cardiomyopathy in the elderly. N Engl J Med 1985; 312: 277–83.CrossRefGoogle Scholar
28Ruskin, JN.The cardiac-arrhythmia suppression trial (CAST) N Engl J Med 1989; 321: 386–88.CrossRefGoogle ScholarPubMed
29Ansari, A.Syndrome of cardiac cachexia and the cachectic heart. Progr Cardiovasc Dis 1987; 30: 45–60.CrossRefGoogle ScholarPubMed
30Valberg, LS, Corbett, WEN, McCorriston, JR, Parker, TO.Excessive loss of plasma protein into the gastrointestinal tract associated with primary myocardial disease. Am J Med 1965; 39: 668–73.CrossRefGoogle ScholarPubMed
31Kubo, SH, Walter, BA, John, DHA, Clark, M, Cody, RJ.Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Ann Intern Med 1987; 147: 1227–230.CrossRefGoogle ScholarPubMed
32Levine, B, Kalman, J, Mayer, L, Fillet, HM, Packer, M.Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236–41.CrossRefGoogle ScholarPubMed
33Williamson, J, Chopin, JM.Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing 1980; 9: 73–80.CrossRefGoogle ScholarPubMed
34Morgan, DB, Davidson, C.Hypokalaemia and diuretics: an analysis of publications. Br Med J 1980; 1: 905–908.CrossRefGoogle Scholar
35Levy, DW, Lye, M.Diuretics and potassium in the elderly. J R Coll Physicians Land 1987; 21: 148–52.Google ScholarPubMed
36Nolan, L, O'Malley, K.Adverse drug reactions in the elderly. Br J Hosp Med 1989; 41: 446–57.Google ScholarPubMed
37MacLennan, WJ.Diuretics in the elderly: how safe? Br Med J 1988; 296: 1551–552.CrossRefGoogle ScholarPubMed
38Shapiro, S, Slone, D, Lewis, GP, Jick, H.Fatal drug reactions among medical inpatients. JAMA 1971; 216: 467–72.CrossRefGoogle ScholarPubMed
39Lye, M.Distribution of body potassium in healthy elderly subjects. Gerontology 1981; 27: 286–92.CrossRefGoogle ScholarPubMed
40Struthers, AD, Whitesmith, R, Reid, JL.Prior thiazide treatment increases adrenaline induced hypokalaemia. Lancet 1983; 1: 358.Google ScholarPubMed
41Myers, MG.Diuretic therapy and ventricular arrhythmias in persons 65 years of age and older. Am J Cardiol 1990; 65: 599–603.CrossRefGoogle ScholarPubMed
42MacFarlane, DG, Dieppe, PA.Diuretic induced gout in elderly women. Br J Rheumatol 1985; 24: 155–57.CrossRefGoogle ScholarPubMed
43Drinka, PJ, Nolten, WE.Hazards of treating osteoporosis and hypertension concurrently with calcium vitamin D, and distal diuretics. J Am Geriatr Soc 1984; 32: 405–407.CrossRefGoogle ScholarPubMed
44Roy, WA, Griffin, MR, Downey, W, Melton, WJ.Long term use of thiazide diuretics and risk of hip fracture. Lancet 1989; 1: 687–90.CrossRefGoogle Scholar
45Kulick, D, Roth, A, McIntosh, N, Rahimtoola, SH, Elkayam, U.Resistance to isorbide dinitrate in patients with severe chronic heart failure: Incidence and attempt at hemodynamic prediction. J Am Coll Cardiol 1988; 12: 1023–28.CrossRefGoogle Scholar
46Colucci, WS, Wynne, J, Holman, BL, Braunwald, E.Long-term therapy of heart failure with prazosin: a randomized double blind trial. Am J Cardiol 1980; 45: 337–43.CrossRefGoogle ScholarPubMed
47Packer, M, Meller, J, Medina, N, Yushak, M, Gorlin, R.Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic congestive heart failure. N Engl J Med 1982; 306: 57–62.CrossRefGoogle Scholar
48Franciosa, JA, Jordan, RA, Wilen, MM, Leddy, CL.Minoxidil in patients with left heart failure: contrasting hemodynamic and clinical effects in a controlled trial. Circulation 1984; 70: 63–69.CrossRefGoogle ScholarPubMed
49Cohn, JN, Archibald, DG, Ziesche, S et al. , Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986; 314: 1547–552.CrossRefGoogle Scholar
50Rahimtoola, SH.The pharmacologic treatment of chronic congestive heart failure. Circulation 1989; 80: 693–99.CrossRefGoogle ScholarPubMed
51Cohn, JN, Johnson, G, Ziesche, S et al. A comparison of enalapril with hydralazine – isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303–10.CrossRefGoogle ScholarPubMed
52Pfeffer, MA, Pfeffer, JM, Steinberg, C, Finn, P.Survival after an experimental myocardial infarction – beneficial effects of long term therapy with captopril. Circulation 1985; 72: 406–12.CrossRefGoogle ScholarPubMed
53White, HD, Norris, RM, Brown, MA et al. Left ventricular end systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44–51.CrossRefGoogle ScholarPubMed
54Sharpe, N, Smith, H, Murphy, J, Hannan, S.Treatment of patients wih symptomless LV dysfunction after myocardial infarction. Lancet 1988; 1: 255–59.CrossRefGoogle Scholar
55Swedberg, K, Held, P, Kjekshus, J et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study (CONSENSUS II). N Engl J Med 1992; 327: 678–84.CrossRefGoogle ScholarPubMed
56The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685–91.CrossRefGoogle Scholar
57The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293–302.CrossRefGoogle Scholar
58A placebo-controlled trial of Captopril in refractory chronic congestive heart failure. Captopril Multicentre Research Group. J Am Coll Cardiol 1983; 2: 755–63.Google Scholar
59Packer, M, Carver, JR, Rodeheffer, RJ et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991; 325: 1468–75.CrossRefGoogle ScholarPubMed
60Lee, DCS, Johnson, RA, Bingham, JB et al. Heart failure in out-patients. N Engl J Med 1982; 306: 699–705.CrossRefGoogle Scholar
61Packer, M, Gheorghiade, M, Young, JB et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin converting enzyme inhibitors. N Engl J Med 1993; 329: 1–7.CrossRefGoogle ScholarPubMed
62Friedman, PJ, Campbell, AJ, Caradoc-Davies, TH.Hypoalbuminaemia in the elderly is due to disease not malnutrition. J Clin Exper Gerontol 1985; 7: 191–205.Google Scholar
63Novak, LP.Ageing, total body potassium, fat free mass and cell mass in males and females between ages 18 and 85 years. J Gerontol 1972; 27: 438–43.CrossRefGoogle ScholarPubMed
64Lye, M. Cardiovascular system – digitalis glycosides. In: Brocklehurst, JC ed. Geriatric pharmacology and therapeutics. Oxford: Blackwell 1984;: 71–86.Google Scholar